alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:10cef45c-c803-4a32-9f98-990adf8cf1b2,g:25120583-7a32-417f-b3d3-17c98c6ef127-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cna="http://www.cna.com/20240506" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cna.com/20240506">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cna-20240506_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cna-20240506_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cna-20240506_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageCoverPage" roleURI="http://www.cna.com/role/CoverPageCoverPage">
        <link:definition>0000001 - Document - Cover Page Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
Unassociated Document


    Exhibit
      4.1

    


    


    January
      23, 2006

    


    l

    


    Dear
      Sirs:

     

    Re: Generex
      Biotechnology Corporation
-
      Amendment to Sep 8 05 and Dec 5 05 Warrants

    


    We
      make
      reference to (a) the common stock purchase warrant issued by Generex
      Biotechnology Corporation (the “Company”)
      to
=
      on
      September 8, 2005 pursuant to which the Company granted to =
      the
      entitlement to purchase up to 609,756 shares of the Company’s common stock at
      $0.82 per share (the “Sep
      Warrant”),
      and
      (b) the common stock purchase warrant issued by the Company to =
      on
      December 5, 2005 pursuant to which the Company granted to =
      the
      entitlement to purchase up to 1,219,512 shares of the Company’s common stock at
      $0.82 per share (the “Dec
      Warrant”)
      (the
      Sep Warrant and the Dec Warrant are hereinafter together referred to as the
      “Warrants”).

    


    The
      Initial Exercise Date (as that term is defined in both the Sep Warrant and
      the
      Dec Warrant) of the Warrants is expressed therein as the 181st
      day
      after the date thereof. The Company hereby confirms that, in consideration
      of
      the immediate exercise by =
      of not
      less than 100% of both the Sep Warrant and the Dec Warrant and the delivery
      to
      the Company of Notices of Exercise in respect thereof on or before the close
      of
      business on January 23, 2006, the Company has agreed to abridge the Initial
      Exercise Date and to honor the aforementioned Notices of Exercise.

    


    Yours
      truly,

    


    Generex
      Biotechnology Corporation

    


    


    


    Mark
      A.
      Fletcher

    Executive
      Vice-President, General Counsel

    maf:hs
[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Page 428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00198]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel; (SEP)--PAR 15-303, Occupational 
Safety and Health Education and Research Centers (ERC).
    Dates and Times: February 11, 2019, 6:00 p.m.-8:00 p.m. EST, 
February 12-13, 2019, 8:30 a.m.-5:00 p.m. EST.
    Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, 
Virginia 22314, (703)837-0440.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Michael Goldcamp, Ph.D., 
Scientific Review Officer, Office of Extramural Programs, CDC, 1095 
Willowdale Road, Morgantown, West Virginia 26505, (304) 285-5951; 
<a href="/cdn-cgi/l/email-protection#2449434b484047454954644740470a434b52"><span class="__cf_email__" data-cfemail="eb868c84878f888a869bab888f88c58c849d">[email protected]</span></a>.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal 
Register notices pertaining to announcements of meetings and other 
committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and 
Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00198 Filed 1-25-19; 8:45 am]
 BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
### -82 -80 -78 -76 -74

36 38 40 

## ★ ▲ ▲ ▲ ▲



## ★ ▲ ▲ ▲ ▲ 

### 500 1000 1500 100 18 12 06 00 10/09 

## NOAA HYSPLIT MODEL 

# Backward trajectory ending at 2300 UTC 09 Oct 07

EDAS Meteorological DataSource★at 38.90 N 76.65 WMeters AGL 

## ★ ■ ■ ■ ■



## ★ ■ ■ ■ ■ 

## ★ ● ● ● ●



## ★ ● ● ● ●
Order entered October 3, 2022

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-22-00698-CV

IN THE INTERST K.W., A CHILD

On Appeal from the 468th Judicial District Court

Collin County, Texas

Trial Court Cause No. 468-55854-2017

ORDER

Before the Court is appellant’s September 29, 2022 motion to extend the time 

to file the jurisdictional brief requested by this Court. We GRANT the motion and

extend the deadline to October 12, 2022. 

/s/ BILL PEDERSEN, III

JUSTICE
DIRECTV HOLDINGS LLC

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of DIRECTV Holdings LLC (the "Corporation") on Form 10-Q for the period ended September 30, 2006
as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael W. Palkovic, Executive Vice President and Chief Financial Officer of the Corporation, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

|/s/ MICHAEL W. PALKOVICMichael W. Palkovic
Executive Vice President and Chief Financial Officer |  | 
|----------------------------------------------------------------------------------------------- |  | 
|November 8, 2006                                                                                |  | 

---



QuickLinks
Searched for **https://www.lca.gov/**

 

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

*Note:* This calendar view maps the number of captures of **https://www.lca.gov/**, *not* how many times the site was actually updated.

Look Up URL in general Internet Archive web collection.
U.S. DEPARTMENT OF TRANSPORTATION 

U.S. ENVIRONMENTAL PROTECTION AGENCY 

MYs 2021-2026 CAFE Proposal - by the Numbers 

All quantities compared to standards issued in 2012 

Calculated based on “Preferred Alternative” Option in NPRM 

Consumer Impacts 

Increased vehicle affordability leading to increased driving of newer, safer, more efficient, and 

cleaner vehicles. 

• A $2,340 reduction in overall average vehicle ownership costs for new vehicles 

o $1,850 reduction in the average required technology costs 

o $490 reduction in ownership costs for financing, insurance, and taxes 

• Over 12,000 fewer crash fatalities over the lifetimes of all vehicles built through MY 2029 

o Up to 1,000 lives saved annually 

Manufacturer Impacts 

Reduced regulatory costs and burdens. Increased new vehicle sales. 

• $252.6 billion reduction in regulatory costs through MY 2029. 

• 1 million additional new vehicle sales through MY 2029. 

• Reduction from 56% to 3% in the percentage of hybrid vehicles needed to comply in MY 

2030. 

• 37.0 mpg projected overall industry average required fuel economy in MYs 2021-2026, 

compared to 46.7 mpg projected requirement in MY 2025 under standards issued in 2012 

Overall Impacts: 

Under the preferred alternative, there will be lower costs, thousands of lives saved, and minimal 

impact to fuel consumption and the environment 

• Over $500 billion reduction in societal costs over the lifetimes of vehicles through MY 2029 

o Technology costs: $252.6 billion 

o Costs attributable to additional fatalities: $77.1 billion 

o Costs attributable to additional injuries: $120.4 billion 

o Costs attributable to additional congestion and noise: $51.9 billion 

• $176 billion in societal net benefits 

• 2-3% increase in daily fuel consumption 

o About 0.5 million barrels per day increase in fuel consumption 

• Increase from 789.11 ppm to 789.76 ppm in atmospheric CO2 concentration in 2100 

o 3/1,000ths of a degree Celsius increase in global average temperature in 2100 

o 8/100ths of a percent increase in atmospheric CO2 concentration in 2100 

• No noticeable impact to net emissions of smog-forming or other “criteria” or toxic air 

pollutants 

EPA-420-F-18-901 

August 2, 2018
### §18113. Prohibition against discrimination on assisted suicide

#### (a) In general

The Federal Government, and any State or local government or health care provider that receives Federal financial assistance under this Act (or under an amendment made by this Act) or any health plan created under this Act (or under an amendment made by this Act), may not subject an individual or institutional health care entity to discrimination on the basis that the entity does not provide any health care item or service furnished for the purpose of causing, or for the purpose of assisting in causing, the death of any individual, such as by assisted suicide, euthanasia, or mercy killing.

#### (b) Definition

In this section, the term "health care entity" includes an individual physician or other health care professional, a hospital, a provider-sponsored organization, a health maintenance organization, a health insurance plan, or any other kind of health care facility, organization, or plan.

#### (c) Construction and treatment of certain services

Nothing in subsection (a) shall be construed to apply to, or to affect, any limitation relating to—

(1) the withholding or withdrawing of medical treatment or medical care;

(2) the withholding or withdrawing of nutrition or hydration;

(3) abortion; or

(4) the use of an item, good, benefit, or service furnished for the purpose of alleviating pain or discomfort, even if such use may increase the risk of death, so long as such item, good, benefit, or service is not also furnished for the purpose of causing, or the purpose of assisting in causing, death, for any reason.

#### (d) Administration

The Office for Civil Rights of the Department of Health and Human Services is designated to receive complaints of discrimination based on this section.

(Pub. L. 111–148, title I, §1553, Mar. 23, 2010, 124 Stat. 259.)

#### **Editorial Notes**

#### References in Text

This Act, referred to in subsec. (a), is Pub. L. 111–148, Mar. 23, 2010, 124 Stat. 119, known as the Patient Protection and Affordable Care Act. For complete classification of this Act to the Code, see Short Title note set out under section 18001 of this title and Tables.
§ 270.30e-2 Reports to shareholders of unit investment trusts. ( a ) At least semiannually every registered unit investment trust substantially all the assets of which consist of securities issued by a management company must transmit to each shareholder of record (including record holders of periodic payment plan certificates), a report containing all the applicable information and financial statements or their equivalent, required by § 270.30d-1 to be included in reports of the management company for the same fiscal period. Each of these reports must be transmitted within the period allowed the management company by § 270.30e-1 for transmitting reports to its shareholders.
( b ) Any report required by this section will be considered transmitted to a shareholder of record if the unit investment trust satisfies the conditions set forth in § 270.30e-1(f) with respect to that shareholder.
[64 FR 62547, Nov. 16, 1999. Redesignated and amended at 66 FR 3759, Jan. 16, 2001]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Nuclear Regulatory Commission

The ACNW will hold a Planning and Procedures meeting on December 13, 2004, Room T-2B3, 11545 Rockville Pike, Rockville, Maryland. 

The entire meeting will be open to public attendance, with the exception of a portion that may be closed pursuant to 5 U.S.C. 552b(c) (2) and (6) to discuss organizational and personnel matters that relate solely to internal personnel rules and practices of ACNW, and information the release of which would constitute a clearly unwarranted invasion of personal privacy. 

The agenda for the subject meeting shall be as follows: 

*Monday, December 13, 2004—1 p.m.-2:15 p.m.*

The Committee will discuss proposed ACNW activities and related matters. The purpose of this meeting is to gather information, analyze relevant issues and facts, and formulate proposed positions and actions, as appropriate, for deliberation by the full Committee. 

Members of the public desiring to provide oral statements and/or written comments should notify the Designated Federal Official, Mr. Howard J. Larson (Telephone: 301/415-6805) between 7:30 a.m. and 4:15 p.m. (e.t.) five days prior to the meeting, if possible, so that appropriate arrangements can be made. Electronic recordings will be permitted only during those portions of the meeting that are open to the public. 

Further information regarding this meeting can be obtained by contacting the Designated Federal Official between 7:30 a.m. and 4:15 p.m. (e.t.). Persons planning to attend this meeting are urged to contact the above named individual at least two working days prior to the meeting to be advised of any potential changes in the agenda. 

Dated: November 23, 2004. 

John H. Flack, 

Acting Branch Chief, ACRS/ACNW. 

[FR Doc. 04-26358 Filed 11-29-04; 8:45 am] 

BILLING CODE 7590-01-P
#### § 38.450 Core Principle 8.

The board of trade shall make public daily information on settlement prices, volume, open interest, and opening and closing ranges for actively traded contracts on the contract market.
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER ON MOTION TO REINSTATE

Appellate case name: Ahmed Zidan v. Alexander Zidan, Individually and Derivatively 

on Behalf of Prime United Petroleum Holding Company, LLC, 

211 HWY 332 Kwik Kar, LLC and 401 Legacy Car Wash

Appellate case number: 01-19-00140-CV

Trial court case number: 2018-59233

Trial court: 165th District Court of Harris County

Date motion filed: October 23, 2020

Party filing motion: Appellant

On October 15, 2020, we abated this appeal to allow the trial court with dominant 

jurisdiction to continue, unimpeded by the suit in Harris County. On October 23, 2020, appellant 

filed a motion for rehearing. On November 17, 2020, appellee filed a response to appellant’s 

motion for rehearing. We interpret appellant’s motion as a motion to reinstate. Appellant’s motion 

to reinstate is denied. 

It is so ORDERED.

Judge’s signature: /s/ Sherry Radack

 Acting individually  Acting for the Court

Date: ___December 15, 2020_____
### NUMBER 13
- 20
- 00 410
- CV 

## COURT OF APPEALS
THIRTEENTH DISTRICT OF TEXAS
CORPUS CHRISTI

– EDINBURG

IN THE INTEREST OF C.N.L., P.A.L., D.J.L., D.D.L., B.M.L., J.J.L., AND J.J.L., CHILDREN

On Appellant s’ First Motion for Extension of Time to File Brief

.


## ORDER

Before Chief Justice Contreras and Justices Longoria and Perkes Order Per Curiam
This is an appeal of a final order terminating parental rights. The notice of appeal
was filed on September 28 , 2020 , and a ppellan ts’ brief is due November 2 , 2020. Appellant s D .L. and J.M. filed a motion for extension of time seeking an extension until
No vember 23, 2020, to file the brief

. Appellant s’ counsel certified that appellee, the Department of Family and Protective Services, is unopposed to the motion

. Appeals in parental termination and child protection cases are governed by the rules of appellate procedure for accelerated appeals, but include additional expedited2 deadlines and procedures. See T EX

. R. A PP

. P. 28.4; T EX

. R. J UD

. A DMIN

. 6.2(a). The
interm ediate appellate courts are directed to ensure “as far as reasonably possible” that appeals in such cases are brought to final disposition within 180 days of the date the notice of appeal is filed. See T EX

. R. J UD

. A DMIN

. 6.2(a). Accordingly , it is the policy of this
Court to limit extensions of time in such cases

. See T EX

. R. A PP

. P. 38.6(d).
W e hereby GRANT appellant s’ first motion for extension of time and ORDER appellant s’ brief to be filed on or before 5:00 p.m. on Monday, November 2 3 , 2020 . No
further motions for extension of time will be entertained in the absence of extraordinary
circumstances

. IT IS SO ORDERED

. PER CURIAM
D elivered and filed the 27 th day of October, 20 20

.
[Federal Register Volume 69, Number 235 (Wednesday, December 8, 2004)]
[Notices]
[Page 71055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-26987]


-----------------------------------------------------------------------

FEDERAL MARITIME COMMISSION


Ocean Transportation Intermediary License Revocations

    The Federal Maritime Commission hereby gives notice that the 
following Ocean Transportation Intermediary licenses have been revoked 
pursuant to section 19 of the Shipping Act of 1984 (46 U.S.C. app. 
1718) and the regulations of the Commission pertaining to the licensing 
of Ocean Transportation Intermediaries, effective on the corresponding 
date shown below:

License Number: 016472N.
Name: (CAL.) KTL International, Inc.
Address: 3039 East Ana Street, Rancho Dominguez, CA 90221.
Date Revoked: November 25, 2004.
Reason: Failed to maintain a valid bond.

License Number: 013258N.
Name: Cargoline (USA) Inc.
Address: 33 Washington Street, 16th FL, Newark, NJ 07102.
Date Revoked: November 13, 2004.
Reason: Failed to maintain a valid bond.

License Number: 000861F.
Name: George J. Young & Co.
Address: 110 W. Ocean Blvd., Suite 622, Long Beach, CA 90801.
Date Revoked: November 14, 2004.
Reason: Failed to maintain a valid bond.

License Number: 018401F.
Name: Inlogix Corp.
Address: Lot 6 Monterrey Avenue, Geoconsult Bldg., San Juan, PR 00920.
Date Revoked: November 18, 2004.
Reason: Failed to maintain a valid bond.

License Number: 013489N.
Name: J.R. International Shipping, Inc.
Address: 25 Commerce Drive, Cranford, NJ 07016.
Date Revoked: November 7, 2004.
Reason: Failed to maintain a valid bond.

License Number: 017997F.
Name: Royal Lonestar Marketing, Inc. dba Royal Lonestar Forwarding.
Address: 3340 Greens Road, Bldg. A, Suite 880, Houston, TX 77032.
Date Revoked: November 3, 2004.
Reason: Failed to maintain a valid bond.

License Number: 011170F.
Name: Sage Freight Systems Inc. dba Sage Container Lines.
Address: 182-30 150th Road, Suite 108, Jamaica, NY 11413.
Date Revoked: November 23, 2004.
Reason: Failed to maintain a valid bond.

License Number: 017411N.
Name: Sunfreight Cargo International, Inc.
Address: 4130 Saviers Road, Oxnard, CA 93033.
Date Revoked: November 15, 2004.
Reason: Failed to maintain a valid bond.

License Number: 000489F.
Name: T.A. Coleman & Co., Inc.
Address: 393 Jericho Turnpike, Mineola, NY 11501.
Date Revoked: October 24, 2004.
Reason: Failed to maintain a valid bond.

License Number: 017747N.
Name: Tomcar Investment USA, Inc.
Address: 10773 NW. 58th Street, Suite 296, Miami, FL 33178.
Date Revoked: November 7, 2004.
Reason: Failed to maintain a valid bond.

Sandra L. Kusumoto,
Director, Bureau of Certification and Licensing.
[FR Doc. 04-26987 Filed 12-7-04; 8:45 am]
BILLING CODE 6730-01-P
Subpart 5313.1 - PROCEDURES

Parent topic: Part 5313 - Simplified Acquisition Procedures

5313.106-1 Soliciting from a Single Source

(b) For acquisitions that exceed the micro-purchase threshold, but do not exceed the Simplified

Acquisition Threshold, the tailorable Single Source Justification or Single Source Memorandum for

Record template may be used.

5313.106-3 Award and Documentation

(a) See the tailorable Determination of Fair & Reasonable Price template when using Simplified

Acquisition Procedures under FAR 13.1.